ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,135.12
0.56%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theratechnologies Inc (THTX)

  7. Theratechnologies Inc (THTX) News

Theratechnologies (THTX)

Theratechnologies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THTX
DateTimeSourceHeadlineSymbolCompany
10/05/202418:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
09/05/202422:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
09/05/202421:30GlobeNewswire Inc.Theratechnologies Reports on its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
02/05/202412:30GlobeNewswire Inc.Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO MeetingNASDAQ:THTXTheratechnologies Inc
15/04/202421:15GlobeNewswire Inc.Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
11/04/202412:30GlobeNewswire Inc.Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:THTXTheratechnologies Inc
10/04/202412:30GlobeNewswire Inc.Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/04/202412:15IH Market NewsU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherNASDAQ:THTXTheratechnologies Inc
08/04/202421:30GlobeNewswire Inc.Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology PlatformNASDAQ:THTXTheratechnologies Inc
05/04/202416:00GlobeNewswire Inc.Theratechnologies Appoints Elina Tea to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
03/04/202412:30GlobeNewswire Inc.Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
28/03/202411:30GlobeNewswire Inc.Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ PlatformNASDAQ:THTXTheratechnologies Inc
22/03/202413:36GlobeNewswire Inc.Theratechnologies Announces Update on its Preclinical Oncology Research ProgramNASDAQ:THTXTheratechnologies Inc
22/03/202400:00GlobeNewswire Inc.Theratechnologies Appoints Jordan Zwick to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
21/03/202411:30GlobeNewswire Inc.Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
29/02/202421:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
29/02/202421:34GlobeNewswire Inc.Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain TrudeauNASDAQ:THTXTheratechnologies Inc
27/02/202413:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
27/02/202412:30GlobeNewswire Inc.Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDANASDAQ:THTXTheratechnologies Inc
21/02/202413:01Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:THTXTheratechnologies Inc
21/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
21/02/202412:30GlobeNewswire Inc.Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 GuidanceNASDAQ:THTXTheratechnologies Inc
20/02/202412:30GlobeNewswire Inc.Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of ActionNASDAQ:THTXTheratechnologies Inc
15/02/202413:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
15/02/202412:30GlobeNewswire Inc.Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
06/02/202419:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
06/02/202412:30GlobeNewswire Inc.Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
01/02/202416:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
24/01/202418:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
24/01/202412:00GlobeNewswire Inc.Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLANASDAQ:THTXTheratechnologies Inc
 Showing the most relevant articles for your search:NASDAQ:THTX

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
GKP
Gulf Keystone Petroleum
LSE
SCE
Surface Transforms
LSE
SCLP
Scancell
LSE
OXB
Oxford Biomedica
LSE
AGL
Angle
LSE
ITV
Itv
LSE
PANR
Pantheon Resources
LSE
SRSP
Sirius Petroleum
LSE
EEE
Empire Metals
LSE
GOLD
LSE
ENET
Ethernity Networks
LSE
SYME
Supply@me Capital
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved